PEDRO is a platform supporting the management of the Adverse Drug Reaction (ADR) occurring during the management of Chronic Lymphocytic Leukemia (CLL) patients by facilitating seamless communication between physicians and a specialized support team. To this end, PEDRO provides and ADR management digital platform connecting physicians and experts through peer-to-peer communication, enabling optimal ADR management decisions.
